A Rare Depth Of Experience At The Highest Levels Of Business And Finance

Selected Experience Involving Mergers And Acquisitions

Macaluso LLP assisted a U.S. based family office in the sale of its nanotech portfolio business located in international affiliates in Japan, Singapore, and Israel to a NASDAQ listed company.

M&A, TECHNOLOGY, INTERNATIONAL, COMMERCIALIZATION, SECURITIES OFFERINGS, ASIA, MIDDLE EAST, REGULATORY, CAPITAL MARKETS


Assisted leading medical research institution and related entities in connection with their efforts to commercialize intellectual properties.

HEALTHCARE, COMMERCIALIZATION, M&A, INTERNATIONAL, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, U.S., SOCIAL IMPACT, CAPITAL MARKETS


Acted as advisor to principally U.S. private equity funds and investors making investments in Asia, including in or through China, Japan, Malaysia, Indonesia, Vietnam, Singapore and Hong Kong.

FUNDS, INTERNATIONAL, ASIA, M&A, REGULATORY, SECURITIES OFFERINGS, TECHNOLOGY, HEALTHCARE, AGRICULTURE, CAPITAL MARKETS


Acted as chief strategist in the restructuring of several portfolio companies of a fund in the health care, life science, IP, and tech sectors, commercializing medical related advances of prominent medical research institutions.

COUNSEL SERVICES, HEALTHCARE, TECHNOLOGY, FUNDS, COMMERCIALIZATION, M&A, SECURITIES OFFERINGS, CAPITAL MARKETS


M&A transactions on behalf of acquirers and targets, including partial spin-offs and full divestitures, in connection with restructurings and otherwise of finance companies, banks, and asset-managers as well as companies in the health care and agriculture sectors.

M&A, HEALTHCARE, FINANCIAL SERVICES, AGRICULTURE, INTERNATIONAL, CAPITAL MARKETS


On behalf of several prominent private investment funds, the design and formation of credit opportunity and private equity funds and the structuring and execution of various transactions to acquire, finance, and leverage fund assets on the one hand and to monetize or dispose of fund assets on the other hand.

FUNDS, M&A, INTERNATIONAL, SECURITIES OFFERINGS, REGULATORY, U.S., FINANCIAL SERVICES, CAPITAL MARKETS


Performed pre-IPO and/or pre-PE investment due diligence and managed pre-investment and later the pre-exit strategy relative to companies in various sectors in China including pharmaceutical companies, retailers, advanced robotics, printing, plastics and food and beverage companies.

FUNDS, M&A, HEALTHCARE, TECHNOLOGY, AGRICULTURE, INTERNATIONAL, REGULATORY, CAPITAL MARKETS


Developed an innovative ag financing program with one of the largest agribusiness companies in the world, with facilities ranging from $100 million to $600 million and in connection with its $1.2 billion divestiture of one of its finance subsidiaries.
FINANCIAL SERVICES, AGRICULTURE, ABS, STRUCTURED FINANCE, M&A, CAPITAL MARKETS